Compositions and methods for treating cns disorders
US-2017342102-A1 · Nov 30, 2017 · US
not covered by C07J31/003
not covered by C07J31/003 · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07J31/006 |
| Official title | {not covered by C07J31/003} |
| Display label | not covered by C07J31/003 |
| Total patents | 348 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 14 |
| 2016 | 31 |
| 2017 | 33 |
| 2018 | 38 |
| 2019 | 47 |
| 2020 | 40 |
| 2021 | 34 |
| 2022 | 33 |
| 2023 | 29 |
| 2024 | 20 |
| 2025 | 25 |
| 2026 | 4 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Cholate photoacid generators and photoresists comprising same
US-2017285470-A1 · Oct 5, 2017 · US
Process for preparing bile acid derivatives
US-9777038-B2 · Oct 3, 2017 · US
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
US-9763964-B2 · Sep 19, 2017 · US
Oxysterols and methods of use thereof
US-2017247405-A1 · Aug 31, 2017 · US
19-nor c3, 3-disubstituted c21-n-pyrazolyl steroids and methods of use thereof
US-2017246191-A1 · Aug 31, 2017 · US
17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases
US-9717739-B2 · Aug 1, 2017 · US
Onium salt, resist composition, and patterning process
US-9703193-B2 · Jul 11, 2017 · US
Inhibitors of the farnesoid x receptor and uses in medicine
US-2017152283-A1 · Jun 1, 2017 · US
TGR5 modulators and methods of use thereof
US-9650409-B2 · May 16, 2017 · US
Farnesoid x receptor modulators
US-2017101434-A1 · Apr 13, 2017 · US
Farnesoid X receptor modulators
US-9611289-B2 · Apr 4, 2017 · US
Inhibitors of CYP17A1
US-9611270-B2 · Apr 4, 2017 · US
Process for abiraterone acetate
US-2017051009-A1 · Feb 23, 2017 · US
Inhibitors of the farnesoid X receptor and uses in medicine
US-9540415-B2 · Jan 10, 2017 · US
Novel cholesterol metabolite, 5-cholesten, 3beta-25-diol, disulfate (25hcds) for therapy of metabolic disorders, hyperlipidemia, diabetes, fatty livers diseases and atherosclerosis
US-2016355544-A1 · Dec 8, 2016 · US
Scroll composite having amphiphilic substance inside and method for preparation of the same
US-2016355401-A1 · Dec 8, 2016 · US
19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
US-9512165-B2 · Dec 6, 2016 · US
Onium salt, resist composition, and patterning process
US-2016320698-A1 · Nov 3, 2016 · US
Methods for treatment of inflammatory conditions using S-[4-(3-fleuro-3-methylbutyryloxy)but-2-ynyl]6α, 9α-difluoro-17α-(furan-2-yl) carbonyloxy-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-diene-17β-carbothioate
US-9458187-B2 · Oct 4, 2016 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07J31/006?
- CPC C07J31/006 is the Cooperative Patent Classification code for “not covered by C07J31/003.”
- How many patents are filed under CPC C07J31/006 (not covered by C07J31/003)?
- Our database includes 348 publications tagged with this CPC code.
- Is patent activity under CPC C07J31/006 growing?
- Publication counts under this code: 20 in 2024 vs 25 in 2025 (latest complete years).